Introduction: Pyrazole derivatives are considered important scaffolds that possess cocktails of pharmacological activities. However, no study has assessed their effects on the proliferation of macrophages. Aim: In this study, 4-nitrophenyl derivative (HL 1 ) containing the 1H-pyrazol-5-ol moiety was synthesized, characterized, and assessed for antibacterial as well as cell proliferative effects. Materials and Methods: HL 1 was characterized using an elemental analyzer, thermogravimetric analysis, X-ray diffraction, and various spectrophotometric methods. The antibacterial effect of HL 1 on three Gram-positive bacterial strains, namely Enterococcus faecalis, Staphylococcus aureus, and Staphylococcus epidermidis, and three Gram-negative bacterial strains, namely Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa, was determined using the minimal inhibition assays. The RAW 267.4 macrophage cell line was used to assess the effect of HL 1 on mitochondrial activity using the CellTiter® blue cell viability assay. Results: The thermogram and diffractogram plots registered thermal stability slightly above the melting point of HL 1 and a crystal size of 13.01 nm, respectively. The characterization studies indicated the presence of azomethine moiety at 1701.65 cm
INTRODUCTION
T he azole, specifically the five-membered 1H-pyrazol-5-ol-scaffold, has attracted attention due to the pharmacological potency acquired when coupled to an aromatic aldehyde unit. [1] The presence of the pyrazole nucleus can be traced in many pharmaceutically established drugs with diverse therapeutic activities. [2, 3] Over the past two decades, pyrazoleSchiff base derivatives have found diverse applications due to their potent antioxidant, antimicrobial, antimycobacterial, antiinflammatory, non-enzymatic protein glycation inhibition, gastric secretion stimulation, and antidepressant properties. [4] [5] [6] Many Schiff bases derived from pyrazole have been synthesized by the condensation of 1H-pyrazol-3-amine derivatives and different aromatic aldehydes or ketones leading to polysubstituted pyrazole as reported by Baluja and Chanda. [7] The continuous search for novel biologically active pyrazole derivatives coupled with the development of drug resistance
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of microbial strains has made it necessary to investigate the influence of these compounds on biological systems. Despite the research done to develop pharmaceutically potent pyrazole derivatives, no study has targeted the effect of pyrazole on the macrophages, an essential component of the mammalian immune system. Macrophages are widely distributed throughout the different tissues where they play a role in the phagocytosis of virally infected and cancerous cells as well as extrinsic threats such as pathogen invasion or breach in tissue. [8] In this study, we investigated the antimicrobial, antioxidant, and RAW 246.7 macrophage proliferative effects of 4-nitrophenyl derivative containing the 2H-pyrazol-3-ol.
Experimental details

Chemicals
All chemicals and reagents used in this study were of analytical grade; 3-amino-5-hydroxypyrazole, 4-nitrobenzaldehyde, 2,2-diphenyl-1-picrylhydrazyl (DPPH), quercetin, gallic acid, ascorbic acid, penicillin G, streptomycin, dimethyl sulfoxide (DMSO), hydrogen peroxide, 2,2′-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS), and potassium persulfate from Sigma-Aldrich (St. Louis, MO). Potassium ferricyanide, trichloroacetic acid, and ferric chloride were purchased from Merck (Darmstadt, Germany). Dulbecco's Modified Eagle Mmedium (DMEM) and fetal bovine serum (FBS) were obtained from Thermo Fisher Scientific (Waltham, MA). Others such as phosphate buffer, ethanol, and glacial acetic acid were purchased from Promark and Rochelle Chemicals (Johannesburg, South Africa), respectively.
Instrumentation
The percentage elemental composition of the 3-(E)-(((4-nitrophenyl) methylidene) amino)-1H-pyrazol-5-ol was measured using aLECO analyzer (CHNS628 analyser, Lakeview, MI). The maximum absorption, as well as the melting point, was measured using a UV-visible spectrophotometer (Agilent Technologies Cary 60, Santa Clara, CA) and Stuart digital apparatus (Vernon Hills, IL), respectively. 1 H-and nuclear magnetic resonance ( 13 C-NMR) chemical shifts (ppm) were recorded using a 400 MHz NMR spectrometer (Agilent Technologies). Thermal response was monitored on a PerkinElmer, Thermogravimetric Analyzer (Perkin Elmer, Waltham, MA) operated at a temperature ranging between 30 and 900°C at a heating rate of 10°C/ min under a nitrogen atmosphere. The X-ray diffractogram (XRD) was recorded on a ZEISS Sigma 300 diffractometer (Zeiss, Oberkochen, Germany). The Spectrum 400 Fouriertransform infrared (FT-IR) (PerkinElmer) scanning between 4000 and 400 cm −1 was used to determine the functional groups.
Synthesis of 5-[(4-Nitro-Benzylidene)-Amino]-2H-Pyrazol-3-ol
An ethanolic solution of 3-amino-5-hydroxypyrazole (0.99 g; 9.98 mmol) was mixed with 4-nitrobenzaldehyde (3.02 g; 19.98 mmol) in 95% of ethanol. To the mixture, 0.5 mL of glacial acetic acid was introduced and refluxed for 8 h. The product (HL 1 ) obtained was filtered, washed several times 95% ethanol, recrystallized from cold ethanol solution, and dried in an oven at 40°C. The chemical formulation of the structure of HL 1 is shown in Figure 1 .
Electronic absorption study
The wavelength maximum of HL 1 was determined at room temperature, and the molar absorptivity coefficient was calculated from the Lambert-Beer equation 1:
Where A is the absorbance, b is the path length, C is the concentration of HL 1 (mol/L), and ε λ max is the molar absorption coefficient (Lmol
).
XRD study
The XRD was investigated at 40 kV and 40 mA with Cu-Kα (λ = 1.5406 Å) radiation, and the crystallite size (D) was calculated using Scherrer equation (2) .
Where K is the equipment constant (0.94), λ is the wavelength (1.5406 Å ), and β is the integral height to width of the diffraction peak.
Antioxidant Assays
The antioxidant activity of HL 1 was evaluated and compared with three positive controls; quercetin, gallic acid, and ascorbic acid. 
Ferric Reducing Power
The ferric reducing activity was determined according to the method of Oyaizu. [12] In brief, a 0.5 mL aliquot of HL 1 was mixed with 2 mL phosphate buffer (0.2 M, pH 6.8) and 2 mL potassium ferricyanide (0.03 µM) . The mixture was incubated for 30 min at 45°C, followed by the addition of 2 mL of 0.61 mM trichloroacetic acid. A 2-mL portion of the above mixtures was transferred into 2 mL of distilled water and 0.4 mL ferric chloride (0.1% w/v) in a test tube. Then, the absorbance was measured at 700 nm after10 min, and the reducing power was estimated as a function of the absorbance. The same protocol was applied to the controls, and all determinations were carried out in triplicate.
Cell culture
A murine macrophage cell line RAW 264.7 (Cellonex, Johannesburg, South Africa) was cultured and maintained in complete cell culture medium consisting of DMEM supplemented with 10% FBS and antibiotics (10,000 U/ml penicillin G and 10 mg/mL streptomycin) at 37°C in a 5% CO 2 incubator (ESCO, Horsham, PA). The culture medium was replaced with fresh medium every 3 days until the cells were 80% confluent. The cells were washed, trypsinized, and prepared for the cell proliferation assay.
Cell proliferation assay
The effect of HL 1 on the viability of the RAW 264.7 cell line was evaluated using the CellTiter® Blue Cell Viability Assay (Promega, Cat. No. G8081, Madison, WI) according to the manufacturer's instructions with a few modifications. The RAW 264.7 cells were seeded in a 96-well microtiter plate (100 µL per well) at a concentration of 5 × 10 4 cells/mL in complete cell culture medium and incubated at 37°C in a 5% humidified CO 2 incubator. After 24 h of incubation, the cell culture medium was replaced with fresh complete cell culture medium containing different concentrations of the HL 1 (6.25, 12.5, 25, 50, and 100 µg/mL). Four control groups were set up consisting of (i) cell culture medium only (negative control to determine background absorbance), (ii) untreated cells (vehicle control), (iii) medium with 0.1% DMSO (used as solvent for compound), and (iv) cells treated with hydrogen peroxide (H 2 O 2 ) used as the negative control. After treatment, the cells were incubated for different time intervals (24, 96 , and 168 h) at 37°C in a humidified 5% CO 2 incubator. At the end of each incubation period, 20 µL/well of CellTiter® Blue Reagent was added to each well containing the remaining culture medium. The plate was then agitated for 10 s and incubated at 37°C for 4 h in a humidified 5% CO 2 incubator. Thereafter, 100 µl medium containing CellTiter® Blue reagent was transferred into a 96-well microtiter plate, and the absorbance of the dissolved resorufin dye was determined at 570 and 600 nm, respectively, using an EPOCH 2 (BioTek, Winooski, VT) plate reader.
Antibacterial property
Bacterial strains
The microorganisms used in the present investigation included reference strains from the American Type Culture Collection 
Antibacterial activity
The antibacterial activity of the synthesized compound (HL 1 ) was evaluated against the selected bacterial strains using the broth microdilution method as described by de Rapper et al. [13] and Akhalwaya et al. [14] with slight modifications. A 1000 mg/mL stock solution of HL 1 , dissolved in DMSO, was diluted to a working concentration of 300 mg/mL. Microtiter 96-well plates (Nunc Roskilde, Denmark) were prepared by adding 100 µL sterilized deionized water aseptically to each well. Thereafter, 100 µl of the test compound (HL 1 ) was added to the first row of each microtiter plate. Two-fold serial dilutions were carried out down each column to obtain concentrations from 150 to 1.17 mg/mL at a total volume of 100 µL per well. Standardized bacterial cultures (100 µL) at a concentration of 1 × 10 6 colony-forming units/mL were then added to each well of their respective microtiter plates. To detect bacterial growth, 30 µL resazurin indicator dye (0.015%) was added to each well before incubation. Resazurin is an oxidation-reduction indicator that undergoes colorimetric changes (from blue to pink or colorless) in response to reduction by mitochondrial reductases and other diaphorases such as dihydrolipoamide dehydrogenase, NAD(P) H: quinone oxidoreductase, and flavin reductase.
[15] The inoculated microtiter plates were sealed using a sterile adhesive film and incubated at 37°C for 24 h. Amoxycillin (2.5 mg/ mL) (Melford, Chelsworth, United Kingdom) and neomycin (2.5 mg/ml) were included as positive controls. DMSO was included as a negative control to confirm that the solvent did not exert any antibacterial effect and a culture control ensured that the broth could support bacterial growth. According to the Clinical Laboratory Standards Institute guidelines for broth microdilution, [16] the Minimum inhibitory concentration (MIC) is defined as the lowest concentration that completely inhibits the microorganism from multiplying and producing visible growth in the test solution. After inspection of the microtiter plates, 10 µl of the MIC well content was plated on nutrient agar plates and incubated for another hour at 37°C to confirm the antibacterial property of the synthesized compound. All experiments were done in triplicate.
Statistical analysis
Statistical analysis was carried out with OriginPro software (Origin Lab Corporation, Northampton, MA 01060 USA), and the results are expressed as means ± standard deviation.
RESULTS
Chemistry of 5-[(4-Nitro-Benzylidene)-Amino]-2H-Pyrazol-3-ol
The product (HL 1 ) was collected as a regatta powder. Yield 61.8%; m.p 283-285°C; λ max 393 nm and έ [ Figure 2a] ; IR (cm 
Thermal profile of 5-[(4-Nitro-Benzylidene)-Amino]-2H-Pyrazol-3-ol
The thermogravimetric plot of HL 1 is presented in Figure 5 . Four major exothermic peaks corresponding to various thermal responses were observed at 80°C, 100°C, 287°C, and 430°C with a weight loss of 3%, 9%, 20%, and 48%, respectively.
X-ray diffractogram of 5-[(4-Nitro-Benzylidene)-Amino]-2H-Pyrazol-3-ol
The XRD of HL 1 presented in Figure 6 produced a unique diffraction pattern confirming the crystalline nature of HL 1 .
(P < 0.009) reduction in cell viability (83 ± 1%) in comparison to the untreated cells was observed after day 1. When the RAW 264.7 cells were stimulated with HL 1 at 6.5, 12.5, 25, and 50 µg/ml for 4 days, a slight but non-significant increase in cell viability was observed. However, 4 days of stimulation of the RAW 264.7 cells with HL 1 at a concentration of 100 µg/ ml resulted in a further significant (P < 0.001) decrease in cell viability (47 ± 4.68%) compared to the untreated cells (100 ± 1.84%). After 7 days of stimulation with HL 1 at concentrations of 12.5, 25, and 50 µg/ml, percentage cell viability remained slightly higher than that observed in the untreated cells. However, the percentage viability (107 ± 0.96%) in cells stimulated with HL 1 at a concentration of 12.5 µg/ml was highly significant (P < 0.00008) than that observed in the untreated cells (100 ± 3.04%). On the contrary, 7 days of stimulation with HL 1 at a concentration of 6.5 µg/ml resulted in a highly significant (P < 0.0009) decrease in cell viability (76 ± 1.96%) compared to that observed in the untreated cells (100 ± 3.04%). A highly significant (P < 0.0004) decrease in the percentage cell viability (40 ± 4.56%) was observed when HL 1 was used at a concentration of 100 µg/ml in comparison to the untreated cells.
Antibacterial activity
The results of the antibacterial activity of 5-[(4-NitroBenzylidene)-Amino]-2H-Pyrazol-3-ol (HL 1 ) against the six bacterial strains using the broth microdilution method are summarized in Table 2 . Amoxicillin and neomycin (2.5 mg/ ml) were used as reference antibiotics for comparison purposes. The results showed predominately similar antibacterial activity against the selected bacterial strains [ Table 2 ]. The diffractogram registered seven (7) reflection peaks in the range of 0-70° with a maximum at 34.24° and the crystal size determined using Scherrer formula (Eq2) was 13.01 nm.
DISCUSSION
Antioxidant activity of 5-[(4-Nitro-Benzylidene)-Amino]-2H-Pyrazol-3-ol
The antioxidant activities of HL 1 and controls were evaluated using in vitro assays such as DPPH, ABTS, H 2 O 2 scavenging, and ferric reducing power. The IC 50 values for the different assays were obtained from the plots of the % radical inhibition against concentration with r 2 ≥ 0.9635 [ Table 1 ].
The IC 50 values of HL 1 were significant (P < 0.05) compared to the controls. HL 1 showed very potent radical scavenging potential with IC 50 of 0.29 ± 0.09-0.41 ± 0.02 µM [ Table 1 ] and ferric reducing power of 0.0045 ± 0.07 [ Figure 7 ] compared to gallic acid and ascorbic acid, with quercetin being slightly more potent.
Effect of HL 1 on cell viability
When the raw 264.7 cells were stimulated for a day with HL 1 at concentrations of 6.5, 12.5, 25, and 50 µg/ml, an increase in cell viability was observed [ Figure 5 ]. HL 1 at a concentration of 12.5 µg/ml resulted in a highly significant (P < 0.0007) increase in cell viability (127 ± 3%) compared to the untreated cells (100 ± 3%). When HL 1 was used at 100 µg/ml, a significant spectra of HL 1 confirm the presence of azomethine group with proton and carbon signals at δ 9.13 (s, 1H) and δ 156.85 ppm, respectively, and further confirmation was observed at 1701.65 cm −1 on the FT-IR spectrum. [18] The deshielded carbon signal at δ 162.42 ppm confirms the presence of an oxymethine unit of the pyrazol-5-ol moiety. Signals from the aromatic protons were observed at 8. C NMR spectra. [19] Other notable characteristic bands at 1623.64 and 1515.20 cm −1 are attributed to the bending and stretching vibrations of -N-H and -O-N, with the corresponding proton signals at 2.53 (H-2) and 4.01(H-6) ppm, respectively.
Thermal profile of 5-[(4-Nitro-Benzylidene)-Amino]-2H-Pyrazol-3-ol (HL 1 )
The thermal profile of HL 1 at the operating temperature of 30-900 o C and the mechanism of thermal decomposition are presented in Figures 5 and 8 , respectively. The thermogravimetric analysis and DTA plots revealed four thermal events at 80°C, 100°C, 287°C, and 430°C with a corresponding weight loss of 3%, 9%, 20%, and 48%, respectively. The mass loss of 3% at 80°C and 9% at 100°C is attributed to the removal of crystallizing solvent (ethanol) and adsorbed moisture, respectively. The presence of adsorbed moisture is an indication of the hygroscopic nature of HL 1 .
[20] After dehydration, above the melting point (283°C), the first thermal decomposition step took place at 287°C, corresponding to the lost nitrogen (IV) oxide which accounts for 20% of the weight of HL 1 to produce 3-(E) -((phenylmethylidene)amino)-1H-pyrazol-5-ol (III). At a temperature >430°C, the compound (III) carbonizes corresponding to 48% weight loss [ Figure 6 ]. The evaluation of the thermal profile proved that 3-(E) -(((4-nitrophenyl) methylidene) amino)-1H-pyrazol-5-ol is slightly stable above the melting point. Thereafter, the integrity of the compound becomes compromised due to the denitration leading to the production of 3-(E)-((phenylmethylidene)amino)-1H-pyrazol-5-oI (III).
XRD
The X-ray powder diffraction study was conducted to study the specific chemistry, atomic arrangement, and crystallinity of HL 1 . The diffractogram of HL 1 recorded seven crystalline peaks confirming the crystallinity of HL 1 . The nanocrystalline size of 13.01 nm calculated from the Scherrer equation (2) is an important residual factor associated with the ordered arrangement of atoms in a crystalline, which directly influences the compound properties. [21] According to the study of Carballo and Wolf [22] , the rate of biological interaction of a compound is significantly influenced by the crystallite size. Hence, the large crystallite size is expected to have some degree of influence on the biological activity.
Antioxidant activity of HL 1
Derivatives of pyrazole have been known to exhibit significant in vitro antioxidant activity and in vivo COX-II inhibition. [23] Our investigation into the antioxidant potential of HL 1 showed similar scavenging potentials against DPPH, ABTS acid, and peroxide radicals [ Table 1 ] compared to the acid controls as observed in previous studies.
[ [24] [25] [26] The total antioxidant potential of HL 1 was effectively estimated by the as a function of HL 1 to donate either an electron to the vacant d-orbital or proton which invariably is measured as the reduction capacity of the evaluated compound. [27] Consequently, in this study, the reducing power is in the order of quercetin > HL 1 > gallic acid > ascorbic acid [ Figure 7 ]. There is a significant difference (P < 0.05) in the ferric reducing power, with HL 1 showing comparative activity to quercetin. The scavenging potentials and total reducing power can be justified by the structural features of the ring structures such as the hydroxyl, carboxylic acid, or lactone groups. [28] The number of -OH groups and the ability to delocalize electrons within the complex structure to stabilize the phenoxy and carboxylate ions [29, 30] influenced the antioxidant activity of quercetin relative to HL 1 .
Antibacterial activity
Infectious diseases, resulting in approximately 50,000 deaths per day, remain one of the leading health-related problems worldwide. The efficacy of many of the currently available antibacterial agents that kill or prevent the reproduction of microorganisms is rapidly declining due to the emergence of multidrug-resistant organisms. Furthermore, infections caused by multidrug-resistant bacteria are associated with prolonged treatment regimens, resulting in an increased financial burden on the health-care sector.
[31] The urgent need for the development of new classes of antibacterial agents is evident. However, the synthesis of new antibacterial agents is restricted by the search for new substances that are effective against microorganisms but non-toxic to mammalian cells. The antibacterial properties of pyrazole and many pyrazole derivatives have been investigated with variable degrees of antibacterial potential. [1] In the current study, the newly synthesized lactam-type Schiff base pyrazole derivative was tested for its antibacterial activity against E. faecalis, S. aureus, S. epidermidis, K. pneumoniae, E. coli, and P. aeruginosa with amoxicillin. The investigation revealed that HL 1 was active against all the tested bacterial strains and that the solvent, DMSO, had no inhibitory effect on any of the tested bacterial strains [ Table 2 ]. Based on the results, a similar MIC value (9.38 mg/ml) was recorded for K. pneumonia, E. coli, P. aeruginosa, and E. faecalis, with a slightly lower MIC value (4.69 mg/ml) for S. epidermidis and S. aureus. Studies have indicated that Gram-negative bacteria are more resistant to antimicrobial agents as compared to Gram-positive bacteria due to the presence of a mostly impermeable cell wall. [32] On comparing the antibacterial potential of the newly synthesized Schiff base with that of the reference compounds (amoxicillin and neomycin), it was concluded that HL 1 displayed poor antibacterial activity against all tested bacterial strains.
Effect of HL 1 on cell proliferation
The results showed that HL 1 at low concentrations, particularly at 12.5 µg/ml, significantly increased the number of viable macrophage cells [ Figure 9 ]. The increase in cell viability is, perhaps, due to an increase in mitochondrial activity which could have resulted from the proliferation or self-renewal of the macrophages. The link between an increase in mitochondrial activity and cell proliferation has been established in various studies. [33, 34] Clearly, the results showed that HL 1 could act as a macrophage growth factor although the exact mode of action remains unknown. It is possible that the HL 1 could have promoted the proliferation of macrophages through the upregulation of the colonystimulating factor (CSF) receptors. The proliferation or self-renewal of macrophages in vivo has been documented and is shown to result from the presence of growth factors and cytokines such as macrophage M-CSF or granulocytemacrophage stimulating factor GM-CS F [8] and IL-4 [8, 35] or IL-34. [36] Similar reasons could be forwarded for the proliferation of macrophages in this study. Furthermore, the proliferation of macrophages has been linked to the increased expression of the CSF 1 receptor.
[8] Although a time-based decrease in the proliferative capability of HL 1 was observed, while proliferation remained above that observed in the untreated macrophages. The ability for HL 1 to induce a sustained increase in macrophage proliferation could either result in a positive or negative outcome. The proliferation of resident macrophages is desirable for pathogen control or wound repair, especially in a situation, where an inflammatory response could have resulted in the depletion of the resident macrophages. [35] On the contrary, macrophage proliferation has also been associated with inflammatory pathology such as in obesity-associated tissue inflammation [37] and type II diabetes.
[38] However, the negative or positive outcome largely would depend on whether the resident macrophages are either classically M1 or M2 activated. The M1 macrophages are associated with the production of pro-inflammatory cytokine and phagocytosis and play a vital role in the initiation of , 50, and 100 µg/ml for 1, 4, and 7 days. The untreated cells were used as a negative control, whereas the H 2 O 2 was used as a positive control. The error bars indicate the standard error of the mean of quadruplicate experiments. *Indicates that the mean had P < 0.05 in comparison to the untreated cells. **Indicates that the mean had P < 0.0001 in comparison to the untreated control an immune response, whereas the M2 macrophages induce proliferation and are associated with wound healing and tissue repair. [39] The potential applications that might involve HL 1 should take into cognizance the ability of this compound to induce and maintain macrophage proliferation.
CONCLUSION
Our study underlines the fact that this pyrazole derivative (HL 1 ) is stable beyond the melting point with potent antioxidant potentials but poor antibacterial activity. Future work will focus on profiling the cytokines and chemokines produced by the macrophages in response to HL 1 . Furthermore, gene and protein expression studies will be done to establish the influence that HL 1 may have on the expression of CSF-1R. This will provide some information on the mechanism through which HL 1 was able to induce and sustain macrophage proliferation. This approach could provide a basis for the practical applications of HL 1 .
